Neumega
| Covered Uses: | All FDA-approved indications not otherwise excluded from Part D. |
| Exclusion Criteria: | |
| Required Medical Information: | Patient has experienced severe thrombocytopenia (e.g., platelet count less than equal to 20,000/mcL) from previous chemotherapy OR for patient is considered to be at high risk for the development of severe thrombocytopenia. |
| Age Restrictions: | |
| Prescriber Restrictions: | |
| Coverage Duration: | 12 months |
| Other Criteria: | |
| Excluded Drug Criteria: |
Last Modified on 12/19/2012